• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初级保健中的痴呆症评估:来自三个管理式医疗系统的研究结果。

Dementia assessment in primary care: results from a study in three managed care systems.

作者信息

Boise Linda, Neal Margaret B, Kaye Jeffrey

机构信息

Layton Aging and Alzheimer Disease Research Center, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97201, USA.

出版信息

J Gerontol A Biol Sci Med Sci. 2004 Jun;59(6):M621-6. doi: 10.1093/gerona/59.6.m621.

DOI:10.1093/gerona/59.6.m621
PMID:15215282
Abstract

BACKGROUND

Prior research has found that dementia is often undiagnosed in primary care, but there has been limited research on whether physicians respond to symptoms, behaviors, or other events that may be indicators of dementia.

METHODS

A cross-sectional cohort study design was used to screen 553 patients aged 75 years or older for dementia in 3 managed health care systems in Portland, Oregon. For participants determined to be cognitively impaired, their medical charts were reviewed to determine if they had experienced adverse events, had been clinically evaluated for possible dementia, had received a diagnosis of dementia, or had been offered treatment.

RESULTS

Nearly 43% of participants were identified as cognitively impaired: 29.7% were classified as mildly cognitively impaired (MI) and 13.7% as moderately to severely cognitively impaired (MSI). Eighteen percent of the MI group and 34.8% of the MSI group had evidence in their medical chart of having been clinically evaluated for dementia. None of the MI group and only 4.3% of the MSI group had been offered a cholinesterase inhibitor. Nearly two thirds (61.6%) of the MI and three fourths (75.4%) of the MSI participants had experienced 1 or more adverse events. Of those who had experienced adverse events, less than one quarter (23.7%) in the MI group and less than one half (44.2%) in the MSI group had received a clinical evaluation for dementia.

CONCLUSIONS

These findings suggest the need for greater attention by primary care physicians to the cognitive functioning of older patients, especially patients who experience adverse events that may be indicators of dementia.

摘要

背景

先前的研究发现,痴呆症在初级保健中常常未被诊断出来,但对于医生是否会对可能是痴呆症指标的症状、行为或其他事件做出反应的研究却很有限。

方法

采用横断面队列研究设计,对俄勒冈州波特兰市3个管理式医疗保健系统中的553名75岁及以上的患者进行痴呆症筛查。对于被确定为认知受损的参与者,审查他们的病历,以确定他们是否经历过不良事件、是否接受过痴呆症的临床评估、是否被诊断为痴呆症或是否接受过治疗。

结果

近43%的参与者被确定为认知受损:29.7%被分类为轻度认知受损(MCI),13.7%为中度至重度认知受损(MSI)。MCI组中有18%、MSI组中有34.8%的病历中有接受痴呆症临床评估的证据。MCI组中无人、MSI组中仅有4.3%的人接受过胆碱酯酶抑制剂治疗。近三分之二(61.6%)的MCI参与者和四分之三(75.4%)的MSI参与者经历过1次或更多次不良事件。在经历过不良事件的人中,MCI组中不到四分之一(23.7%)、MSI组中不到一半(44.2%)的人接受过痴呆症的临床评估。

结论

这些发现表明,初级保健医生需要更加关注老年患者的认知功能,尤其是那些经历过可能是痴呆症指标的不良事件的患者。

相似文献

1
Dementia assessment in primary care: results from a study in three managed care systems.初级保健中的痴呆症评估:来自三个管理式医疗系统的研究结果。
J Gerontol A Biol Sci Med Sci. 2004 Jun;59(6):M621-6. doi: 10.1093/gerona/59.6.m621.
2
3
Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey.基层医疗中认知障碍的检测与管理:钢铁谷老年人调查
J Am Geriatr Soc. 2004 Oct;52(10):1668-75. doi: 10.1111/j.1532-5415.2004.52459.x.
4
5
Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.《痴呆评定量表-2》及认知增强剂在认知障碍和痴呆诊断与治疗中的应用
J S C Med Assoc. 2004 Feb;100(2):32-8.
6
Are nursing home patients with dementia diagnosis at increased risk for inadequate pain treatment?患有痴呆症诊断的养老院患者接受疼痛治疗不足的风险是否更高?
Int J Geriatr Psychiatry. 2005 Aug;20(8):730-7. doi: 10.1002/gps.1350.
7
Rivastigmine for vascular cognitive impairment.卡巴拉汀用于治疗血管性认知障碍。
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD004744. doi: 10.1002/14651858.CD004744.pub3.
8
Galantamine for vascular cognitive impairment.加兰他敏用于治疗血管性认知障碍。
Cochrane Database Syst Rev. 2006 Jan 25(4):CD004746. doi: 10.1002/14651858.CD004746.pub2.
9
Prevalence of positive screening test for cognitive impairment among elderly urogynecologic patients.老年泌尿妇科患者认知障碍筛查试验阳性的患病率。
Am J Obstet Gynecol. 2016 Nov;215(5):663.e1-663.e6. doi: 10.1016/j.ajog.2016.06.012. Epub 2016 Jun 16.
10
Diagnosing cognitive impairment and dementia in primary health care -- a more active approach is needed.在初级卫生保健中诊断认知障碍和痴呆——需要一种更积极主动的方法。
Age Ageing. 2003 Nov;32(6):606-12. doi: 10.1093/ageing/afg097.

引用本文的文献

1
A Stakeholder-Engaged Process to Design and Implement the Assessment of Cognitive Complaints Toolkit for Alzheimer's Disease (ACCT-AD) in Primary Care.一种利益相关者参与的过程,用于设计和实施初级保健中阿尔茨海默病认知主诉评估工具包(ACCT-AD)。
Res Sq. 2025 Jul 29:rs.3.rs-7134103. doi: 10.21203/rs.3.rs-7134103/v1.
2
Assessing Alzheimer's disease knowledge among Egyptian medical students in the context of recent educational reforms.在近期教育改革背景下评估埃及医科学生对阿尔茨海默病的了解情况。
BMC Med Educ. 2025 May 5;25(1):654. doi: 10.1186/s12909-025-07258-9.
3
Feasibility and Acceptability of Implementing a Digital Cognitive Assessment for Alzheimer Disease and Related Dementias in Primary Care.
在初级保健中实施针对阿尔茨海默病及相关痴呆症的数字认知评估的可行性和可接受性。
Ann Fam Med. 2025 May 27;23(3):191-198. doi: 10.1370/afm.240293.
4
Feasibility and Acceptability of a Technology-Mediated Fall Risk Prevention Intervention for Older Adults With Mild Cognitive Impairment.针对轻度认知障碍老年人的技术介导跌倒风险预防干预措施的可行性与可接受性
J Gerontol A Biol Sci Med Sci. 2025 May 5;80(6). doi: 10.1093/gerona/glaf043.
5
Effectiveness and utilization of a cognitive screening program for primary geriatric care.一项针对老年初级护理的认知筛查项目的有效性及应用情况
Alzheimers Res Ther. 2025 Jan 17;17(1):23. doi: 10.1186/s13195-024-01637-y.
6
Paving the way for Alzheimer's disease blood-based biomarkers in primary care.为初级保健中基于血液的阿尔茨海默病生物标志物铺平道路。
Alzheimers Dement. 2025 Jan;21(1):e14203. doi: 10.1002/alz.14203. Epub 2024 Dec 30.
7
Beyond electronic health record data: leveraging natural language processing and machine learning to uncover cognitive insights from patient-nurse verbal communications.超越电子健康记录数据:利用自然语言处理和机器学习从患者与护士的言语交流中挖掘认知见解。
J Am Med Inform Assoc. 2025 Feb 1;32(2):328-340. doi: 10.1093/jamia/ocae300.
8
A tailored intervention for the detection of patients with coronary heart disease and mental or cognitive comorbidities in the German primary care setting: qualitative evaluation of implementation success.针对德国初级保健环境中伴有精神或认知合并症的冠心病患者的定制干预:实施成功的定性评估。
BMC Health Serv Res. 2024 Nov 22;24(1):1454. doi: 10.1186/s12913-024-11841-z.
9
The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Brain Health Trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithm.电子健康记录阿尔茨海默病和痴呆风险评估规则(eRADAR)脑健康试验:一项低成本痴呆检测算法嵌入式实用临床试验方案。
Contemp Clin Trials. 2023 Dec;135:107356. doi: 10.1016/j.cct.2023.107356. Epub 2023 Oct 17.
10
ADscreen: A speech processing-based screening system for automatic identification of patients with Alzheimer's disease and related dementia.ADscreen:一种基于语音处理的筛查系统,用于自动识别阿尔茨海默病和相关痴呆患者。
Artif Intell Med. 2023 Sep;143:102624. doi: 10.1016/j.artmed.2023.102624. Epub 2023 Jul 17.